A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 138
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CB1R
Long Form : CB1 receptor
No. Year Title Co-occurring Abbreviation
2022 Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex. DSE, DSI, E/I
2022 Chronic use of cannabis might impair sensory error processing in the cerebellum through endocannabinoid dysregulation. ---
2022 Enhancing Endocannabinoid Signaling via β-Catenin in the Nucleus Accumbens Attenuates PTSD- and Depression-like Behavior of Male Rats. FAAH, mGluR5, NAc
2022 Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum. ---
2021 ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro. ACPA, NSCLC
2021 Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder. ASD, CSF
2021 Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597. FAAH, SHR, WKY
2021 Cerebral μ-opioid and CB1 receptor systems have distinct roles in human feeding behavior. DEBQ, MOR, PET
2021 Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia. ---
10  2021 Identification of BiP as a CB1 Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse Brain. ---
11  2021 Lateral habenula cannabinoid CB1 receptor involvement in drug-associated impulsive behavior. 5-CSRTT, eCB, LHb, SUDs
12  2021 Maternal omega-3 intake differentially affects the endocannabinoid system in the progeny`s neocortex and hippocampus: Impact on synaptic markers. 2-AG, CB2R, ECS, n-3Sup, PUFA
13  2021 Methamphetamine Blocks Adenosine A2A Receptor Activation via Sigma 1 and Cannabinoid CB1 Receptors. A2AR, GPCR, MAPK, sigma1R
14  2021 Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects. 5-HT2AR, THC, TM
15  2021 Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease. AD, AEA, ECS, FAAH, LTP
16  2021 The Absence of the Transient Receptor Potential Vanilloid 1 Directly Impacts on the Expression and Localization of the Endocannabinoid System in the Mouse Hippocampus. CRIP1a, FAAH, MAGL, ML, MPP, TRPV1
17  2020 A novel allosteric modulator of the cannabinoid CB1 receptor ameliorates hyperdopaminergia endophenotypes in rodent models. CB, DAT-KO, eCBs, GluN1KD, PPI
18  2020 Anxious Behavior of Adult CD1 Mice Perinatally Exposed to Low Concentrations of Ethanol Correlates With Morphological Changes in Cingulate Cortex and Amygdala. 5-HT1AR, EtOH, PEE
19  2020 Control of glutamate release by complexes of adenosine and cannabinoid receptors. A2AR
20  2020 HIV Tat Protein Selectively Impairs CB1 Receptor-Mediated Presynaptic Inhibition at Excitatory But Not Inhibitory Synapses. 2-AG, Delta9-THC, DSE, eCB, HAND, Tat
21  2020 Inhibition of Fatty Acid Amide Hydrolase (FAAH) During Adolescence and Exposure to Early Life Stress may Exacerbate Depression-like Behaviors in Male and Female Rats. BLA, ELS, FAAH, GRs, PFC
22  2020 Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure. THC
23  2020 Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases. CB2R
24  2020 The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers. SNP
25  2020 The therapeutic potential of second and third generation CB1R antagonists. ---
26  2020 Transient gain of function of cannabinoid CB1 receptors in the control of frontocortical glucose consumption in a rat model of Type-1 diabetes. T1D
27  2020 Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents. DA
28  2019 A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis. ---
29  2019 Activation of NPRs and UCP1-independent pathway following CB1R antagonist treatment is associated with adipose tissue beiging in fat-fed male dogs. HFD, NP, PL, RIM, WAT
30  2019 Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Delta9-Tetrahydrocannabinol-Induced Cognitive Impairment. A2AR, CBD, Delta9-THC
31  2019 Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors. CBD, lPAG
32  2019 Cell-Type- and Endocannabinoid-Specific Synapse Connectivity in the Adult Nucleus Accumbens Core. BLA, MSNs, NAc, PFC, TRPV1R, vHipp
33  2019 Combined Loss of Ghrelin Receptor and Cannabinoid CB1 Receptor in Mice Decreases Survival but does not Additively Reduce Body Weight or Eating. BW, GHS-R, GHSR
34  2019 Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia. APDs, CBD, GABA, HPC, MIA, PFC
35  2019 Endocannabinoid System and Alcohol Abuse Disorders. AUD, CB, CB2R, CNS, Delta9-THC, eCB, FASD
36  2019 Novel object recognition memory in REM sleep-deprived rats: Role of the cannabinoid CB1 receptor. NOR, RSD
37  2019 Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. ---
38  2019 Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders. FAAH, FABP, MAGL, SUD
39  2019 Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis. NOAELs
40  2019 Remote CB1 receptor antagonist administration reveals multiple sites of tonic and phasic endocannabinoid neuroendocrine regulation. ACTH, AuD, BLA, BST, CORT, HPA, LS, PVN
41  2019 Signaling molecules targeting cannabinoid receptors: Hemopressin and related peptides. CBRs
42  2019 Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson's Disease. PD
43  2018 Bidirectional influence of amygdala beta1-adrenoceptors blockade on cannabinoid signaling in contextual and auditory fear memory. BLA
44  2018 Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells. ON
45  2018 CB1 receptors in the paraventricular nucleus of the hypothalamus modulate the release of 5-HT and GABA to stimulate food intake in rats. PVN
46  2018 Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function. BLA, SRs
47  2018 Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice. eCB, EtOH, WIN
48  2018 Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB1R after stroke in rodents. ---
49  2018 Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor. Ago-PAMs
50  2018 Neuronal Calcium and cAMP Cross-Talk Mediated by Cannabinoid CB1 Receptor and EF-Hand Calcium Sensor Interactions. ---
51  2018 Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol. CB2R, NAcc, OEA, PCR, TH, VTA
52  2018 Sex difference in brain CB1 receptor availability in man. ECS, PET
53  2018 Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation. CIPN, CNS, PRCBs, PrNMI
54  2017 Atypical Endocannabinoid Signaling Initiates a New Form of Memory-Related Plasticity at a Cortical Input to Hippocampus. ECBs, LPP, LTP
55  2017 Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates. aVTA, BLA, CPA, CPP, DA, NAc, pVTA, VTA
56  2017 Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation. A2ARs, i.p, NOR
57  2017 Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis. iNOS
58  2017 Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing. AEA, CSD, TG
59  2017 Endocannabinoid signaling in hypothalamic circuits regulates arousal from general anesthesia in mice. DMH, eCB, PeF, PFC, VLPO
60  2017 Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice. MA
61  2017 Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats. ---
62  2017 Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet. ---
63  2017 Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors. MSNs
64  2017 Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling. ARC, DIO, MC4R
65  2017 Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum. A2AR
66  2016 Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling. AEA, eCB, FAAH, PD
67  2016 Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens. BLA, NAc, NASh
68  2016 Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus. BDNF, CPP, CREB, ERK, NAc
69  2016 Cannabinoid Receptor Interacting Protein 1a Competition with beta-Arrestin for CB1 Receptor Binding Sites. CRIP1a
70  2016 Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood. BLA, ES, GRs, PFC, WIN
71  2016 Dissecting striatal adenosine-cannabinoid receptor interactions. New clues from rats over-expressing adenosine A2A receptors. A2AR
72  2016 Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex. eCBs, ECS, PFC
73  2016 Involvement of medial prefrontal cortex alpha-2 adrenoceptors on memory acquisition deficit induced by arachidonylcyclopropylamide, a cannabinoid CB1 receptor agonist, in rats; possible involvement of Ca2+ channels. ACPA, mPFC
74  2016 [The endocannabinoid system and bone]. CB2R
75  2015 A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. AZ, GPCR, PET
76  2015 Cannabinoid receptor agonists modulate calcium channels in rat retinal Muller cells. 2-AG, AEA, CB2Rs
77  2015 Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist. ---
78  2015 Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. 5-HT2AR, THC
79  2015 Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations. CCK, DAT, ir, PPI, PV
80  2015 Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice. 2-AG, AEA, eCB, eEPSP, FAAH, MAGL, MSNs, PD, PINK1, sEPSCs
81  2015 Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic-pituitary-adrenal axis and other consequences of daily repeated stress. ACTH, eCBs, HPA
82  2015 Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase. 2-AG, eCBs, MAFP, MAGL, WT
83  2015 Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice. BCCAO, EA, GCI, GluR2
84  2015 N-Oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte. OLGly
85  2015 Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis. EAE, MNCs
86  2015 Role of the basolateral amygdala dopamine receptors in arachidonylcyclopropylamide-induced fear learning deficits. ACPA, BLA, DA, DAergic
87  2014 2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter. DATs
88  2014 Cannabinoid CB1 receptor signaling dichotomously modulates inhibitory and excitatory synaptic transmission in rat inner retina. ACs, BCs, mEPSCs, mIPSCs, RGCs, WIN
89  2014 Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing. BLA, GRs, PFC, PTSD, SRs
90  2014 Experience salience gates endocannabinoid signaling at hypothalamic synapses. ---
91  2013 Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats. EA, MACO, STAT3
92  2013 beta-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia. GPCRs, MOR
93  2013 CB1 cannabinoid receptor-mediated aggressive behavior. 5-HTT, 5HT1Br, AMY, BLA, BMA, COMT, DRT, MAOA, WT
94  2013 Dissociation of the pharmacological effects of THC by mTOR blockade. mTOR, THC
95  2013 Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice. ---
96  2013 Glycogen synthase kinase-3beta is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke. EA, GSK-3beta
97  2013 Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase. AEA, FAAH, HFD, MUFA, SCD1
98  2013 Rod photoreceptors express GPR55 in the adult vervet monkey retina. CB2R, GPR55
99  2013 Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors. ERK, MAPK, PKA, TEA, WIN
100  2013 The CB1 cannabinoid receptor mediates glucocorticoid-induced effects on behavioural and neuronal responses during lactation. BNST, DEX, OT